The fact that there is actual data for/in peer review is very encouraging. I have to believe that there is enough there for a peer review and they believe in the results and the statistics. These guys have been around long enough to know they can't put junk out for peer review. Things will probably slow down due to the holidays. My fear is the timetable is running out on GNBT/NGIO vaccine ... which is too bad because I'm not too thrilled with the current crop of mRNA technology
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links